Select Page

Our Posts

Read our most recent articles and announcements

Solarvest Launches World’s First Organic DHA Omega-3 Fruit Gummy Drops for Children

Dec 21, 2020 | Press Releases

Vancouver, B.C., December 21st. 2020 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSX-V:SVS), Solarvest, through it’s 100% wholly owned subsidiary Eversea™ is pleased to announce plans to launch its Organic Omega-3 nutritional Gummy Fruit Drops for children after the year-end holiday break. The fruit drop has been produced and passed quality control under high standards from our German contract manufacturer. The final phase is to confirm the quality of the product after the logistics of shipping and packaging which is underway. The Company’s first of its kind nutritional gummy product will be an exceptional competitor in the large and rapidly growing gummy supplement market. The organic gummy contains Solarvest’s proprietary, certified organic, Omega-3 DHA powder, a sustainable, plant based powder designed for organic, vegetarian and vegan consumers.

The Company is actively working to add unique products to satisfy the demand for premium organic, Omega-3 and plant-based health products. This first labelled product will soon commence sales in the USA and be available from the company’s E-commerce website (www.eversea.ca) and through Amazon. Eversea will be capable of providing organic oriented retailers with house branded products based on our patented ingredient (differentiation), so that they may take benefit from the exten-sive market demand for the product’s unique characteristics, particularly for organic and vegan diets.

The company also announces the completion of its USA infrastructure and logistics system for order processing. Our west coast distribution point is located close to the primary and most important market for organic and plant based supplements/foods. In addition this strategic location is close to organic food processors, sustainable oriented consumers and the organic baby food market. The facility is capable of nation-wide distribution.

The Eversea Omega-3 powder is USDA and EU Organic Certified and produced from the Company’s sustainable, proprietary process. Gerri Greenham, CEO, notes that, “Our omega 3’s are sustainable because they are expressed in algae and grown in controlled facilities which eliminates the need to harvest marine species. Our technology produces an organically certified, highly bioavailable long-chain Omega-3 that cannot be produced by common plant species such as flaxseed or hemp which only contain ALA Omega-3. Our customers are buying a product to improve health so they want an organic product which has a clean label of ingredients.” The Company also intends to sell the powder supplement to organic food processors and mar-keters, such as baby food suppliers, to facilitate the development of enhanced patent-protected products. The Company also intends to pursue other premium animal health applications such as high Omega-3 eggs, pet supplements and food. “

Eversea has also initiated a second product run with its German-based organically certified manufacturer to supplement inventory levels domestically and initiate international sales. Recognizing that Eversea’s organically certified product holds a competitive advantage with several differentiating factors focused on sustainability, environmental conservation, bioavailability and purity, the Company will be able to deliver alternatives for the adult, seniors, infant formula and maternity markets to com-plement its adolescent offering.

Market Overview
“The EPA and DHA omega-3 finished product market size reached US$44.2 billion in 2019. as stated in the 2020 Global EPA &DHA Finished Goods Report. Market dynamics and new product development are driving increased growth in certain product categories and across several regions of the world, leading the global EPA and DHA consumer product market to a projected annual growth rate of 6.1% for 2020–2021”.

“The global gummy vitamins market size is estimated to be valued at USD 5.9 billion in 2020 and projected to reach USD 10.6 billion by 2025, recording a CAGR of 12.5%, in terms of value” as stated by Reportlinker in Oct 27, 2020 PRNewswirepress release.

About Solarvest:
Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides it with an extremely flexible sys-tem capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has successfully demonstrated the expression of BMP, a high value therapeutic protein, viral antigens (immune stimulating pro-teins), and Cecropins (antimicrobial peptide/protein). The company has initiated a program for the expression of CBD and THC to be produced in GMP fermentation facilities.

For further information contact:
Email: invest@solarvest.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company’s expectations and projections.